ELDN — Eledon Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ELDN
| date | signal | measured base rate |
|---|---|---|
| 2026-07-28 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-06-22 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
| 2026-03-23 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-03-20 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-31 | Gros David-Alexandre C Chief Executive Officer | Shares withheld for tax | 194.8K | 3.38 | 658.4K |
| 2026-07-31 | Perrin Steven President | Shares withheld for tax | 72.1K | 3.38 | 243.8K |
| 2026-07-31 | Gros David-Alexandre C Chief Executive Officer | Grant or award | 354.5K | 0.00 | 0 |
| 2026-07-31 | Perrin Steven President | Grant or award | 152.4K | 0.00 | 0 |
| 2026-01-10 | Kirk Allan Director | Option exercise | 3.4K | 0.00 | 0 |
| 2026-01-10 | Lee June Director | Option exercise | 3.4K | 0.00 | 0 |
| 2026-01-10 | McBride John S. Director | Option exercise | 3.4K | 0.00 | 0 |
| 2026-01-10 | Hillson Jan Director | Option exercise | 3.4K | 0.00 | 0 |
| 2026-01-10 | Robinson James A. Jr. Director | Option exercise | 3.4K | 0.00 | 0 |
| 2026-01-10 | Katkin Keith Director | Option exercise | 8.6K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BVF INC/IL | 19.4M | 6.3M |
| BlackRock, Inc. | 13.5M | 4.4M |
| Defilade Capital Management, L.P. | 11.0M | 3.6M |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.1M | 3.3M |
| Ensign Peak Advisors, Inc | 7.6M | 2.5M |
| Zimmer Partners, LP | 5.8M | 1.9M |
| GEODE CAPITAL MANAGEMENT, LLC | 5.5M | 1.8M |
| SPHERA FUNDS MANAGEMENT LTD. | 5.5M | 1.8M |
| Catalio Capital Management, LP | 5.1M | 1.6M |
| Blue Owl Capital Holdings LP | 4.4M | 1.4M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-07-31 | on EDGAR ↗ |
| 4 | 2026-08-04 | 2026-07-31 | on EDGAR ↗ |
| SCHEDULE 13G | 2026-07-31 | — | on EDGAR ↗ |
| 8-K | 2026-06-22 | 2026-06-18 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-05-15 | — | on EDGAR ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Eledon Pharmaceuticals, Inc. (ELDN) filed form 8-K · 2026-08-13 · SEC EDGAR
Ask the AI about ELDN
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →